These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21910991)

  • 1. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis.
    Saxena A; Martin-Blondel G; Mars LT; Liblau RS
    FEBS Lett; 2011 Dec; 585(23):3758-63. PubMed ID: 21910991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ; Suidan GL; McDole J; Pirko I
    Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
    Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
    J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):545-67. PubMed ID: 21284556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
    Aristimuño C; de Andrés C; Bartolomé M; de las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
    Clin Immunol; 2010 Feb; 134(2):148-57. PubMed ID: 19900844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cells in multiple sclerosis.
    Severson C; Hafler DA
    Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
    Jensen J; Langkilde AR; Frederiksen JL; Sellebjerg F
    J Neuroimmunol; 2006 Oct; 179(1-2):163-72. PubMed ID: 16919783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis.
    Somma P; Ristori G; Battistini L; Cannoni S; Borsellino G; Diamantini A; Salvetti M; Sorrentino R; Fiorillo MT
    J Leukoc Biol; 2007 Mar; 81(3):696-710. PubMed ID: 17110420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine CD8+ regulatory T lymphocytes: the new era.
    Pomié C; Ménager-Marcq I; van Meerwijk JP
    Hum Immunol; 2008 Nov; 69(11):708-14. PubMed ID: 18817827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA; Fugger L
    Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability.
    Melzer N; Meuth SG; Wiendl H
    FASEB J; 2009 Nov; 23(11):3659-73. PubMed ID: 19567369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.